Tango Therapeutics, Inc. (TNGX)
USD 2.79
(-4.12%)
USD 2.79
(-4.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -117.98 Million | -109.08 Million | -59.52 Million | 70.07 Million | -24.8 Million |
| Net Income | -101.74 Million | -108.17 Million | -58.23 Million | -51.97 Million | -14.09 Million |
| Depreciation & Amortization | 2.41 Million | 1.6 Million | 897 Thousand | 718 Thousand | 643 Thousand |
| Deferred income taxes | -295 Thousand | - | - | - | - |
| Stock-based compensation | 19.07 Million | 14.23 Million | 7.83 Million | 1.76 Million | 1.69 Million |
| Change in working capital | -37.96 Million | -18.49 Million | -11.34 Million | 118.67 Million | 1.69 Million |
| Other non-cash items | 529 Thousand | 1.75 Million | 1.32 Million | 890 Thousand | -14.74 Million |
| Investing Cash Flow | 41.42 Million | 26.39 Million | -183.43 Million | -145.46 Million | 848 Thousand |
| Investments in PPE | -1.52 Million | -7.69 Million | -1.83 Million | -1.1 Million | -1.81 Million |
| Acquisitions | -42.95 Million | -34.09 Million | 181.59 Million | - | - |
| Investment purchases | -310.57 Million | -208.5 Million | -372.36 Million | -207.54 Million | - |
| Sales/Maturities of investments | 353.52 Million | 242.59 Million | 190.76 Million | 63.22 Million | - |
| Other Investing Activities | 42.95 Million | 34.09 Million | -181.59 Million | -40 Thousand | 2.66 Million |
| Financing Cash Flow | 82.4 Million | 1.61 Million | 357.32 Million | 80.88 Million | 11 Million |
| Debt repayment | - | - | -342.11 Million | -655 Thousand | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 80.01 Million | 1.62 Million | 29.99 Million | 80.88 Million | - |
| Other Financing Activities | 2.38 Million | -8000.00 | 327.33 Million | 655 Thousand | 11 Million |
| Accounts receivables | 2 Million | - | - | -2 Million | - |
| Accounts payables | -1.7 Million | 1.09 Million | 1.23 Million | 1.17 Million | - |
| Inventory | -6.73 Million | - | - | 422 Thousand | - |
| Other working capital | -31.52 Million | -19.59 Million | -12.57 Million | 119.08 Million | 1.69 Million |
| Cash at beginning of period | 63.95 Million | 145.02 Million | 30.66 Million | 25.16 Million | - |
| Cash at end of period | 69.8 Million | 63.95 Million | 145.02 Million | 30.66 Million | 25.16 Million |
| Capital Expenditure | -1.52 Million | -7.69 Million | -1.83 Million | -1.1 Million | -1.81 Million |
| Effect of forex changes on cash | - | - | - | - | 38.12 Million |
| Net cash flow / Change in cash | 5.85 Million | -81.06 Million | 114.36 Million | 5.49 Million | 25.16 Million |
| Free Cash Flow | -119.5 Million | -116.77 Million | -61.36 Million | 68.96 Million | -26.62 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -25.55 Million | -37.91 Million | -30.76 Million | -101.74 Million | -22.26 Million | -20.71 Million |
| Depreciation & Amortization | 632 Thousand | 625 Thousand | 617 Thousand | 2.41 Million | 613 Thousand | 604 Thousand |
| Deferred income taxes | - | - | -2.36 Million | -295 Thousand | 739 Thousand | -1.76 Million |
| Stock-based compensation | 7.53 Million | 6.71 Million | 4.87 Million | 19.07 Million | 4.86 Million | 5.12 Million |
| Change in working capital | -5.99 Million | -6.83 Million | -750 Thousand | -37.96 Million | -16.01 Million | -9.51 Million |
| Other non-cash items | 11.33 Million | 6.47 Million | 914 Thousand | 529 Thousand | 933 Thousand | 1.79 Million |
| Investing Cash Flow | 12.69 Million | -11.2 Million | 33.85 Million | 41.42 Million | -56.66 Million | 32.68 Million |
| Investments in PPE | -320 Thousand | -195 Thousand | -226 Thousand | -1.52 Million | -16 Thousand | -664 Thousand |
| Acquisitions | - | - | -34.07 Million | -42.95 Million | 56.64 Million | -33.35 Million |
| Investment purchases | -48.61 Million | -120.26 Million | -51.02 Million | -310.57 Million | -156.23 Million | -50.77 Million |
| Sales/Maturities of investments | 61.63 Million | 109.25 Million | 85.1 Million | 353.52 Million | 99.59 Million | 84.12 Million |
| Other Investing Activities | 13.01 Million | -11 Million | 34.07 Million | 42.95 Million | -56.64 Million | 33.35 Million |
| Financing Cash Flow | 1.31 Million | 42.98 Million | 1.46 Million | 82.4 Million | 80.28 Million | 586 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.31 Million | 42.98 Million | 841 Thousand | 80.01 Million | 80.45 Million | 586 Thousand |
| Other Financing Activities | 1.31 Million | 42.98 Million | 626 Thousand | 2.38 Million | -178 Thousand | 586 Thousand |
| Accounts receivables | - | - | - | 2 Million | - | - |
| Accounts payables | -2.76 Million | 1.04 Million | -88 Thousand | -1.7 Million | -1.95 Million | -1.21 Million |
| Inventory | - | - | - | -6.73 Million | - | - |
| Other working capital | -3.22 Million | -7.87 Million | -662 Thousand | -31.52 Million | -14.06 Million | -8.3 Million |
| Cash at beginning of period | 61.16 Million | 67.24 Million | 61.95 Million | 63.95 Million | 69.47 Million | 60.67 Million |
| Cash at end of period | 51.56 Million | 61.16 Million | 69.8 Million | 69.8 Million | 61.95 Million | 69.47 Million |
| Capital Expenditure | -320 Thousand | -195 Thousand | -226 Thousand | -1.52 Million | -16 Thousand | -664 Thousand |
| Effect of forex changes on cash | - | - | 7.64 Million | - | - | -7.64 Million |
| Net cash flow / Change in cash | -9.59 Million | -6.07 Million | 7.85 Million | 5.85 Million | -7.51 Million | 8.8 Million |
| Free Cash Flow | -23.92 Million | -38.05 Million | -27.69 Million | -119.5 Million | -31.15 Million | -25.13 Million |
EQH
NAUBF
GIPIF
DELTACORP
9078
TELIA